Innovent Announces the Establishment of the Scientific Advisory Board

SAN FRANCISCO and SUZHOU, China: SAN FRANCISCO and SUZHOU, China, Aug. 8, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announces today the establishment of Scientific Advisory...

Click to view original post